Preview

Tuberculosis and Lung Diseases

Advanced search

Impact of concurrent diabetes on the intensity of systematic inflammatory response syndrome and nutritive status of pulmonary tuberculosis patients

Abstract

52 pulmonary tuberculosis patients with concurrent diabetes and 76 pulmonary tuberculosis patients without concurrent diabetes (control group) have been examined. Systemic inflammation response syndrome (SIRS) has been evaluated by the concentration in the blood serum (plasma) of C-reactive protein, A serum amyloid protein, α1 -antitrypsin, haptoglobin and fibrinogen; nutritive status has been assessed by body mass index and concentrations in the blood serum of general protein, albumin and transthyretin. It has been found out that SIRS in those with concurrent conditions was less expressed compared to the control group. In particular in 56.9% of them the rates of C-reactive protein were within normal limits (in control group in 19.7%, p < 0.01). When evaluating the nutritive status in pulmonary tuberculosis patients with concurrent diabetes as per transthyretin and general protein, the protein deprivation (nitrogenous) has been found out along with paradox tendency in albumin and body mass index increase. The control group demonstrated less expressed signs of protein deprivation, but they were followed by the adequate reduction of albumin and body mass index. The detected changes allow presuming that the negative effect of diabetes on the course of pulmonary tuberculosis is determined by defective formation of SIRS, destroying its initial protective character and nitrogenous deprivation, restraining the reparation.

About the Authors

G. O. Kaminskaya
Central Research Institute of Tuberculosis
Russian Federation
Moscow


R. Yu. Аbdullaev
Central Research Institute of Tuberculosis
Russian Federation
Moscow


O. G. Komissarova
Central Research Institute of Tuberculosis; Pirogov Russian National Research Medical University
Russian Federation
Moscow


O. O. Konyaeva
Central Research Institute of Tuberculosis
Russian Federation
Moscow


O. O. Berezhnaya
Central Research Institute of Tuberculosis; Pirogov Russian National Research Medical University
Russian Federation
Moscow


References

1. Kovaleva S.I. Sakharny diabet i tuberkulez (dispansernoe issledovanie). Diss. dokt. med. nauk. [Diabetes and tuberculosis (dispensary follow-up). Doct. Diss.]. Moscow, 1979.

2. Sveklina T.S., Talantseva M.S., Barsukov А.V. Metabolic syndrome and inflammation: actual issues of pathogenesis. Klin.-Lab. Diagn., 2013, no. 3, pp. 7-10. (In Russ.)

3. Smurova T.F., Kovaleva S.I. Tuberkulez i sakharny diabet. [Tuberculosis and diabetes.] Moscow, 2007.

4. Teti T. Sing S., Fonseka V. Metabolicheskiy sindrom i peroral’nye sakharosnizhayushhie sredstva. Metabolich. sindrom. (Russ. Ed.: Metabolic syndrome and oral sugar-reducing agents. Metabolic syndrome). Moscow, 2011, pp. 83-101.

5. Chereshnev V.А., Gusev E.Yu., Yurchenko L.N. System inflammation – myth or reality? Vestnik RAN, 2004, vol. 74, no. 3, pp. 219-225. (In Russ.)

6. Harries A.D. TB-diabetes collaborative activities – from evidence to action. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1, pp. 5.

7. Komissarova O.G., Konyayeva O.O., Abdullaev R. Efficacy of MDR-tuberculosis in patients with different types of diabetes mellitus. Int.J.Tuberc. Lung. Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S309

8. Kushner J. The acute phase response: general aspects. Bullieres Clin.Rheumatol., 1994, vol. 8, no. 3, pp. 513-530.

9. Kushner J. Regulation of the acute phase response by cytokines. Prospect. Biol. Med., 1993, vol. 36, no. 4, pp. 611-622.

10. Nystrom P.O. The  systemic inflammatory response syndrome, definition and aetiology. J. Antimicrob. Chemother., 1998, vol. 41, suppl. A, pp. 1-7.

11. Punga V., Yakimova M., Rusakova L. Impact of diabetes mellitus on epidemiological rates of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S308.

12. Robertson C.M., Coopersmith C.M. The systemic inflammatory response syndrome. Microbes Infect., 2006, vol. 8, no. 5, pp. 1382-1389.

13. Ruslami R., Ugarte-Gil C., WalzlG. et  al. TANDEM field studies on TB and diabetes mellitus in Peru, South Africa, Romania and Indonesia. Int.J.Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S6.

14. Unsal A., Aksaray S., Koksal D., Sipit T. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgrad Med., 2005, vol. 81, no. 959, pp. 604-607.

15. Van Grevel R., Beiger M., Ottenhoff Th. et al. Possible mechanisms underlying increased susceptibility of diabetes mellitus patients to TB. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S5.


Review

For citations:


Kaminskaya G.O., Аbdullaev R.Yu., Komissarova O.G., Konyaeva O.O., Berezhnaya O.O. Impact of concurrent diabetes on the intensity of systematic inflammatory response syndrome and nutritive status of pulmonary tuberculosis patients. Tuberculosis and Lung Diseases. 2015;(11):41-46. (In Russ.)

Views: 621


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)